Cost of Revenue of Sonoma Pharmaceuticals, Inc. from 30 Jun 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Sonoma Pharmaceuticals, Inc. quarterly and annual Cost of Revenue in USD history and change rate from 30 Jun 2011 to 31 Dec 2025.
  • Sonoma Pharmaceuticals, Inc. Cost of Revenue for the quarter ending 31 Dec 2025 was $2,699,000, a 18% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Cost of Revenue for 2018 was $10,090,000, a 7.9% increase from 2017.
  • Sonoma Pharmaceuticals, Inc. annual Cost of Revenue for 2017 was $9,348,000, a 31% increase from 2016.
Source SEC data
View on sec.gov
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,699,000 +$405,000 +18% 01 Oct 2025 31 Dec 2025 10-Q 10 Feb 2026 2026 Q3
Q3 2025 $3,484,000 +$1,266,000 +57% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2026 Q2
Q4 2024 $2,294,000 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2026 2026 Q3
Q3 2024 $2,218,000 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2026 Q2
Q2 2012 $32,000 +$12,000 +60% 01 Apr 2012 30 Jun 2012 10-Q/A 31 Aug 2012 2012 Q1
Q2 2011 $20,000 01 Apr 2011 30 Jun 2011 10-Q/A 31 Aug 2012 2012 Q1

Sonoma Pharmaceuticals, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2018 $10,090,000 +$742,000 +7.9% 01 Apr 2018 31 Mar 2019 10-K 01 Jul 2019 2019 FY
2017 $9,348,000 +$2,191,000 +31% 01 Apr 2017 31 Mar 2018 10-K 01 Jul 2019 2019 FY
2016 $7,157,000 01 Apr 2016 31 Mar 2017 10-K 26 Jun 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.